Management of ischemic heart disease in patients with chronic kidney disease
Related Experiment Video
Updated: Jul 2, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Arif Mutwali1, Liam G Glynn, Donal Reddan
1Department of Medicine, Division of Nephrology, National University of Ireland, Galway, Ireland.
Insights
Patients with chronic kidney disease (CKD) and ischemic heart disease (IHD) face high mortality. Aggressive IHD management, including early diagnosis and proven treatments, is crucial for improving outcomes in these high-risk individuals.
Area of Science:
- Cardiology
- Nephrology
- Clinical Medicine
Background:
- Patients with chronic kidney disease (CKD) and ischemic heart disease (IHD) exhibit disproportionately high mortality rates.
- Unlike the general population, CKD patients have not seen improvements in IHD outcomes despite advancements in cardiovascular care.
- This highlights a critical unmet need in managing comorbid CKD and IHD.
Purpose of the Study:
- To review the epidemiology, pathogenesis, and clinical presentation of IHD in CKD patients.
- To evaluate diagnostic modalities for IHD and their limitations in the CKD population.
- To discuss optimal medical and interventional treatment strategies and cardiovascular risk management for these patients.
Main Methods:
- Comprehensive literature review focusing on CKD and IHD.
- Analysis of epidemiological data, pathogenetic mechanisms, and clinical studies.
- Synthesis of current evidence on diagnostic challenges, treatment options, and risk factor modification.
Main Results:
- CKD significantly complicates the diagnosis and management of IHD.
- Established IHD interventions may have limitations or require adaptation in CKD patients.
- Aggressive cardiovascular risk management and a low threshold for diagnostic testing are indicated.
Conclusions:
- An aggressive approach to managing IHD in CKD patients is warranted.
- Early and thorough diagnostic evaluation for IHD should be prioritized.
- Until specific clinical trials are available, all proven strategies for improving outcomes should be considered for this vulnerable population.
Abstract:
Patients with chronic kidney disease (CKD) and ischemic heart disease (IHD) have strikingly high mortality rates. In the general population, there has been a reduction in the mortality and morbidity rates for IHD through the implementation of effective risk-factor-reduction programs and better interventions for patients with established IHD. No such trend has been observed in patients with end-stage kidney disease. This review article addresses the following topics: (i) epidemiology, pathogenesis, clinical CKD patients with IHD; (ii) diagnostic modalities for IHD and their limitation in CKD patients; (iii) medical treatment options and revascularization strategies for these high-risk patients; and (iv) optimal cardiovascular risk management. Generally, in CKD patients with IHD an aggressive approach to IHD is warranted, a low threshold for diagnostic testing should be employed, and awaiting a clinical trial targeting these patients they should be considered for all proven strategies to improve outcomes.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury VI: Nursing Management
Chronic Kidney Disease I: Introduction
